Fecal Microbiota Transplant National Registry

Description

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

Conditions

Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome

Study Overview

Study Details

Study overview

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

Fecal Microbiota Transplant National Registry

Fecal Microbiota Transplant National Registry

Condition
Fecal Microbiota Transplantation
Intervention / Treatment

-

Contacts and Locations

Phoenix

Phoenix Children's Hospital, Phoenix, Arizona, United States, 85016

Los Angeles

Children's Hospital of Los Angeles, Los Angeles, California, United States, 90027

Los Angeles

University of California, Los Angeles, California, United States, 90095

Redwood City

Stanford University, Redwood City, California, United States, 94063

Roseville

Sutter Roseville Medical Center, Roseville, California, United States, 95661

San Francisco

University of California San Francisco, San Francisco, California, United States, 94115

Ventura

Ventura Clinical Trials, Ventura, California, United States, 93003

Hamden

Yale New Haven Hospital, Hamden, Connecticut, United States, 06518

Georgetown

MedStar Georgetown University Hospital, Georgetown, District of Columbia, United States, 20007

Hialeah

Best Quality Research, Inc., Hialeah, Florida, United States, 33016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Recipient Inclusion Criteria
  • * Ability to give informed consent
  • * Receiving FMT or other gut-related microbiota product within 90 days after providing consent
  • * Access to internet and/or telephone
  • * Donor Inclusion
  • * Ability to give informed consent
  • * Providing stool sample for FMT
  • * Incarceration

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

American Gastroenterological Association,

Gary D Wu, MD, PRINCIPAL_INVESTIGATOR, Co-Director, PennCHOP Microbiome Program

Colleen Kelly, MD, PRINCIPAL_INVESTIGATOR, Brown University

Loren Laine, MD, PRINCIPAL_INVESTIGATOR, Yale School of Medicine

Study Record Dates

2027-08